Senior Oncology Field Account Executive

Guardant Health; Illinois; Hybrid; USD 142,000 - 196,000; Full time

Job summary

Guardant Health is seeking an experienced field-based Account Executive for Oncology Sales to promote our liquid biopsy products to oncology providers and offices across assigned territory. You will build strategic plans, drive opportunities with major cancer centers, and collaborate with sales leadership to expand Guardant Health's market presence.

The role requires 2–3 years of direct account management in molecular diagnostics and 3–5 years selling to large oncology practices, with strong

Qualifications

• 2-3 years of direct account management in a molecular diagnostics setting.
• 3-5 years of experience with major cancer centers and oncology practices.
• Ability to present MolDx solutions using Guardant Health’s NGS technology.
• Ability to engage in consultative selling aligning client needs with GHI capabilities.

Responsibilities

• Promote liquid biopsy products to oncology practices, cancer centers, IDNs, and academic medical centers.
• Develop and execute territory business plans with budgets and travel forecasts.
• Collaborate with Head of Sales, RSDs, DSMs, SAMs, and AEs to hit company objectives.
• Build and nurture relationships with KOLs and AMCs within the territory.
• Analyze competitive landscape and provide customer feedback to leadership.

Skills

Account management

Sales experience

Molecular diagnostics

Executive-level communication

Strategic account planning

Education

B.S. in life science/biology/marketing

Job description

Guardant Health is seeking an experienced field-based Account Executive for Oncology Sales to promote our liquid biopsy products to oncology providers and offices across assigned territory. You will build strategic plans, drive opportunities with major cancer centers, and collaborate with sales leadership to expand Guardant Health's market presence.

The role requires 2–3 years of direct account management in molecular diagnostics and 3–5 years selling to large oncology practices, with strong